The growth defect in p38KO tumors is consistent with a strong anti-tumor effect of dominant-negative p38AGF mutant (dn-p38) in the breast cancer MDA-MB-231 model observed in vivo but not in cell culture [8]. This evidence concerns the gene MAPK14 and breast carcinoma.